A tray for securing an implantable device to a carrier member includes a slot configured to retain the carrier member and a receptacle adjacent the slot. The carrier member surrounds a shaft of the implantable device. The receptacle has a first width at a proximal end of the receptacle to receive first and second arms of the implantable device in an initial state in which the first and second arms extend substantially perpendicularly from the shaft. The receptacle has a second width at a distal end of the receptacle for receiving the first and second arms of the implantable device in a collapsed state in which the first and second arms are folded against the shaft such that the carrier member can be slid over the first and second arms to retain the first and second arms. The second width is less than the first width.

An intra-orifice medicament delivery system and formation method involve a housing defining an inner chamber extending along a longitudinal axis, with the chamber wall defining one or more openings therethrough. A retention arrangement extends from the housing, and is adapted to removably retain the housing within a bodily orifice defined by an orifice wall. An osmotic delivery device is disposed within the chamber and includes an osmogen portion and medicament-including portion disposed within a semipermeable membrane. The osmogen portion expands and applies pressure to the medicament-including portion in response to absorption of a liquid from within the bodily orifice permeating through the semipermeable membrane. The medicament-including portion is arranged to emit a medicament in response to the pressure applied by the expanded osmogen portion, with the medicament exiting through a membrane orifice defined by the semipermeable membrane and subsequently exiting the housing through the one or more openings such that the medicament is delivered into the bodily orifice.

An implantable and refillable device for delivering a drug compound is provided. The device comprises a reservoir within which the drug compound is capable of being retained, wherein the reservoir defines a first surface and a second surface opposing the first surface. A release structure comprising a hydrophobic polymer surrounds at least a portion of the reservoir. The release structure is in communication with the reservoir such that the drug compound can pass from the reservoir through the release structure. A septum is positioned adjacent to the first surface of the reservoir and a backing layer is positioned adjacent to the second surface of the reservoir.

An instrument 10 to prepare an intra-uterine device 30 for insertion in uterus 50 of woman, comprising a downfolding device 20, a graduated tube 16, a push rod 17, a stopper 15, and an IUD 30; the downfolding device 20 having a concave depression 41 on either side, an open channel 29 of a circular orifice 46 having a sector of angle measure 46A at least 220° and having an exit opening 48 initially marginally less than an external diameter 22B of the graduated tube 16, a root thickness 37B of the base 37 in-between the open channel 29 such that the exit opening 48 increases by the base 37 flexing; the graduated tube 16 has an internal diameter 22D of a far-end opening 22a of the graduated tube 16 sufficient to capture the stem 33 and both arms 32 of the IUD 30 in a downward triangular formation 51.

In one embodiment, the present invention provides an intrauterine device (IUD) comprising an oval shape, wherein the device comprises a core of magnetic material, an inert material or copper coating the core, wherein the coating comprises a pharmaceutical agent, copper or a combination thereof. Another embodiment provides a method to suppress estrus in a subject comprising inserting an intrauterine device (IUD) comprising an oval shape, wherein the device comprises a core of magnetic material and an inert material or copper coating the core.

In one embodiment, the present invention provides an intrauterine device (IUD) comprising an oval shape, wherein the device comprises a core of magnetic material, an inert material or copper coating the core, wherein the coating comprises a pharmaceutical agent, copper or a combination thereof. Another embodiment provides a method to suppress estrus in a subject comprising inserting an intrauterine device (IUD) comprising an oval shape, wherein the device comprises a core of magnetic material and an inert material or copper coating the core.

The present invention relates to novel intrauterine systems and to methods for manufacturing these systems. An intrauterine system according to the invention comprises a reservoir and a continuous, closed and flexible frame.

Removable marker implants having fiducial markers disposed on multiple elongate members extend and splay laterally outward when deployed thereby providing improved 3D localization and tracking of a portion of the patient's body for stereotactic radiosurgery. Such an approach is particularly useful for tracking of the uterus during radiosurgery treatment of uterine fibroids. Such implants can include an outer sheath that contains the multiple elongate members during delivery into the portion of the body. The elongate members can be slidably disposed within the shaft and advanced into an expanded deployed position by advancement of an applicator shaft or rod within the sheath. Marker implant can also be integrally formed implants with flexible arms having fiducial markers thereon that can be constrained in a sheath for delivery and resiliently splay laterally outward when released from the shaft. Methods of delivery and deployment are also provided.

A contraceptive device for intervaginal use includes a relatively thin, saucer-shaped impermeable body having two opposite side faces wherein one of the two side faces is concave in form and the other of the side faces is convex in form. In addition, the impermeable portion includes an amount of copper-including material which is disposed across the side faces of the impermeable portion so that the copper-including material is exposed at locations across the side faces.

A disposable IUD/IUS inserter is for use in conjunction with a hysteroscope, or blindly, including an inner part which has a flexible metal inner tube, between 1 and 2 mm in diameter. The inner tube has a front end portion including a stylet, the stylet being less than 1 mm in diameter, and the stylet being provided with a stylet tip. The IUD/IUS inserter is further provided with a handle at a rear end of the inner tube, a handle unlocking mechanism for positioning of an IUD or IUS, a release mechanism for releasing of a tail of the IUD/IUS, and an outer tube sized to allow passage through a hysteroscope working channel, the handle unlocking mechanism being connected to the outer tube.